Navigation Links
Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion
Date:11/8/2010

19 77

Arimidex set to lose 54% of its current sales value to generic competitors 77

Lupron (leuprolide; Takeda/Abbott) 81

Drug profile 81

Product positioning 81

SWOT analysis 83

Brand forecast to 2019 83

Lupron will be the top selling antihormonal therapy in 2019, with sales in excess of $1 billion 83

Casodex (bicalutamide; AstraZeneca) 85

Drug profile 86

Product positioning 86

SWOT analysis 87

Brand forecast to 2019 88

Patent expiries set to hamper sales of this class-leading brand 88

KEY DEVELOPERS 90

Strategic overview 90

Trends in corporate strategy 91

Strategic lifecycle management is essential in the antihormonals market 91

Commercialization partnerships are common for smaller players 91

AstraZeneca 91

Corporate strategy 91

Oncology antihormonals portfolio assessment 92

Takeda 93

Corporate strategy 93

Oncology antihormonals portfolio assessment 93

Portfolio assessment of other leading companies 94

BIBLIOGRAPHY 96

Journal papers 96

Websites 96

Datamonitor reports 101

Other 102

APPENDIX A - MARKET ASSUMPTIONS 103

Forecasting assumptions 103

New product launches 103

Patent expiries 103

Data definitions, limitations and assumptions 104

Standard units 104

Country group definitions 104

Rest of the World 104

The 'all other EU countries' group 104

The 'Other non-EU countries' group 104

Forecast methodology 105

Derivation of sales forecasts and pricing trends 105

Exchange rates 105

Report methodology 106

APPENDIX B 107

About Datamonitor 107

About Datamonitor Healthcare 107

About the Oncology analysis team 108

Disclaimer 110

List of Tables Table 1: Definition of the cancer market, 2010 6

Table 2: Sales and growth of
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
2. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
3. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
4. High Unemployment Rates in North Carolina Will Continue to Dictate the Decrease of Commercial Health Plan Enrollment and the Increase of Medicaid Enrollment
5. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
6. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
7. Biocon and Pfizer Enter Into Global Commercialization Agreement
8. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
9. OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
10. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
11. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... PLYMOUTH MEETING, Pa. , Aug. 28, 2014 ... surgical community, patients, and media, both for the ... to patient safety. The quick deployment of surgical ... new technology are prompting facilities to evaluate their ... for the entire surgical team.    ...
(Date:8/28/2014)... 2014 Amgen (NASDAQ: AMGN ) ... (BLA) to the U.S. Food and Drug Administration (FDA) ... cholesterol. Evolocumab is an investigational fully human monoclonal antibody ... protein that reduces the liver,s ability to remove low-density ... 1 ­ The BLA ...
(Date:8/28/2014)... ALISO VIEJO , Kalifornien, 28. ... Inc., hat heute den Start der ... Investigational Device Exemption, Forschungsausnahmegenehmigung) zur Beurteilung ... Systems zur Embolisation von Aneurysmen („WEB") ... University of Tennessee, Department of Neurosurgery/Semmes-Murphey ...
Breaking Medicine Technology:Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 2Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 3Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 4Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 6Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 7Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3
(Date:8/28/2014)... vaccine to prevent Ebola virus disease will begin next ... Diseases (NIAID), part of the National Institutes of Health. ... of a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) ... to generate an immune system response in healthy adults. ... in Bethesda, Maryland. , The study is the first ...
(Date:8/28/2014)... 70 and over who identify themselves as ,old, feel ... perceive they have lower value than younger age groups. ... Kent, titled ,Being old and ill, across different countries: ... used data from the European Social Survey. Respondents, who ... self-rate their health., The researchers found that those living ...
(Date:8/28/2014)... August 28, 2014 Vaccine market - ... great interest among other healthcare industry sectors and sub-circles ... demand in vaccine with respect to evolving and spreading ... due to an improved understanding for a well-balanced life ... States. It has led to new opportunities for manufacturing ...
(Date:8/28/2014)... TX (PRWEB) August 28, 2014 After ... Dr. Paul Vitenas is excited to announce the ... of its kind in any city, Mirror Mirror Beauty ... building. , Situated on the corner of Richmond and ... modern architecture, luxurious amenities, and cutting-edge technology in a ...
(Date:8/28/2014)... Steven Reinberg HealthDay ... Treating pre-cancerous skin spots with a type of light therapy ... the lesions with liquid nitrogen, a new study suggests. ... the scalp and face of people with fair complexions who,ve ... of prior research found that people who underwent the light ...
Breaking Medicine News(10 mins):Health News:NIH to Launch human safety study of Ebola vaccine candidate 2Health News:NIH to Launch human safety study of Ebola vaccine candidate 3Health News:NIH to Launch human safety study of Ebola vaccine candidate 4Health News:NIH to Launch human safety study of Ebola vaccine candidate 5Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 3
... ... Hearing Institute (BHI) is urging families across America to make 2010 the year ... in response to new data that underscores the influence family members have in ... of nearly 47,000 households, more than half (51%) of new first-time owners of ...
... ... home top honors in American Spa Magazine,s 2009 Professional,s Choice Award in the Favorite ... ... 8, 2009 -- Oakworks® Inc., the premier U.S. manufacturer of wellness, spa, massage and ...
... , PHOENIX, Dec. 7 To standing cheers, ... (NNU) today unanimously endorsed the creation of the largest union ... and projected a major escalation in campaigns to expand union ... , "The promise of the future has arrived," said Karen ...
... Calif., Dec. 7 Patriot Scientific Corporation (OTC Bulletin ... its Board of Directors and will serve as chair ... 16 years of experience working in the software development ... and the delivery of consulting services for Cognizant Technology ...
... , LOS ANGELES, Dec. 7 Steeped in ... on Crystal Cruises, April 26 "Mind, Body and Spirit" ... the spiritual heritage of the region via personal meetings with ... meditation center, while guest health experts share insights on life ...
... , Department of Health Reminds At-Risk Pennsylvanians to ... federal Centers for Disease Control and Prevention, or CDC, ... flu vaccine to Pennsylvania to date, the state Department ... been distributed to 1,639 certified providers including pediatricians, family ...
Cached Medicine News:Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Patriot Scientific Corporation Announces New Director 2Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: